Clinical trial · Observational
Adrenal Function in Patients With Newly Diagnosed Lung Cancer
Adrenal Cortical Function in Patients With Newly Diagnosed Lung Cancer
NCT00364624CI-TRIAL-00001901completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients with newly diagnosed lung cancer may have hypofunction of the adrenal cortex either from tumour metastasis or other mechanisms. Since lung cancer patient may have to undergo stressful investigation and treatments, undetected hypofunction of the adrenal cortex may be hazardous. Knowledge of the size of the problem may help determine whether routine check is warranted.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adrenal Insufficiency | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically proven primary lung cancer * Newly diagnosed * No specific treatment given * No active infection in the previous week * No general anesthesia in the previous week Exclusion Criteria: * Known adrenal disease * Receiving exogenous systemic corticosteroids * Concomitant illness known to affect adrenal function. e.g. active TB
References
Publications (0)
Data not yet available
No reference posted for this study.